Buy Raloxifene is typically prescribed to treat osteoporosis in postmenopausal women and reduce the risk of invasive breast cancer. The duration of safe use depends on individual health factors and treatment goals. Studies suggest that long-term use of raloxifene, up to seven years, can be effective and generally safe for preventing osteoporotic fractures and reducing breast cancer risk. However, prolonged use may increase the risk of certain side effects such as blood clots. Healthcare providers carefully assess each patient's risk factors, bone density, and overall health to determine the appropriate duration of treatment. Regular monitoring and discussions with a healthcare provider are essential to evaluate the ongoing benefits and risks of raloxifene therapy. Ultimately, treatment duration should be tailored to each individual's needs and regularly re-evaluated to ensure optimal safety and effectiveness.
